Kane Biotech Inc.
KNBIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $6,166 | -$5,034 | -$3,824 | -$4,850 |
| Dep. & Amort. | $218 | $239 | $263 | $188 |
| Deferred Tax | $0 | $0 | $183 | $66 |
| Stock-Based Comp. | $711 | $442 | $280 | $1,092 |
| Change in WC | -$5,835 | -$162 | -$378 | $1,293 |
| Other Non-Cash | -$5,372 | $1,294 | $433 | -$78 |
| Operating Cash Flow | -$4,111 | -$3,222 | -$3,043 | -$2,289 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$25 | -$9 | -$88 | -$354 |
| Net Acquisitions | $10,852 | $0 | $500 | $500 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$560 | -$107 | -$520 | -$520 |
| Investing Cash Flow | $10,268 | -$116 | -$108 | -$374 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6,655 | -$472 | $2,250 | $1,260 |
| Stock Issued | $0 | $416 | $974 | $1,116 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,032 | $3,039 | -$121 | $1,548 |
| Financing Cash Flow | -$7,686 | $2,982 | $3,103 | $2,808 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,530 | -$356 | -$48 | $145 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,889 | $1,105 | $1,153 | $1,008 |
| End Cash | $359 | $749 | $1,105 | $1,153 |
| Free Cash Flow | -$4,201 | -$3,231 | -$3,131 | -$2,643 |